The role of Tc99m sestamibi imaging in predicting clinical response to chemotherapy in lung cancer

dc.contributor.authorDirlik, A
dc.contributor.authorErinc, R
dc.contributor.authorGoksel, T
dc.contributor.authorArgon, M
dc.contributor.authorKarakus, H
dc.contributor.authorOzhan, M
dc.contributor.authorBurak, Z
dc.date.accessioned2019-10-27T18:25:11Z
dc.date.available2019-10-27T18:25:11Z
dc.date.issued1999
dc.departmentEge Üniversitesien_US
dc.identifier.endpage1151en_US
dc.identifier.issn0340-6997
dc.identifier.issue9en_US
dc.identifier.startpage1151en_US
dc.identifier.urihttps://hdl.handle.net/11454/36277
dc.identifier.volume26en_US
dc.identifier.wosWOS:000082614100766en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherSpringer Verlagen_US
dc.relation.ispartofEuropean Journal of Nuclear Medicineen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleThe role of Tc99m sestamibi imaging in predicting clinical response to chemotherapy in lung canceren_US
dc.typeConference Objecten_US

Dosyalar